Sign In
Free Newsletter
BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated)
Earlier this year, the Franklin Lakes-based company unveiled plans to divest the divisions to focus on its core business.
BD finalizes $4.2B acquisition of Edwards Lifesciences critical care unit
The newly renamed BD Advanced Patient Monitoring’s devices are used in more than 10,000 hospitals worldwide to help medical teams better understand patients’ cardiovascular conditions.
Quest, BD collaborating on CDx solutions to match patients with treatments
“This strategic collaboration with BD will combine our expertise in developing and validating biomarkers and assays with BD's leadership in flow cytometry to offer a fully integrated solution on a larger scale," said William Finger, vice president and general manager, Pharma Services, for Quest Diagnostics.
BD to sell surgical instrument business for $540M
The sale to Ohio-based STERIS is part of the Franklin Lakes company's efforts to streamline its product portfolio and manufacturing network.
NJBIZ Conversations: Dave Hickey
BD Executive Vice President and President of Life Sciences Dave Hickey describes the company's new multiple virus test, its importance in combatting future outbreaks and other significant developments in the field.
BD launches automated infectious disease diagnostic platform
The development can be loaded with 1,700 specimens and is capable of delivering up to 1,000 sample results in 24 hours.
